ABPI blister pack carbon footprint tool
This tool was developed for the ABPI by the Carbon Trust with contributions from the ABPI, AstraZeneca, GlaxoSmithKline, Janssen (J&J), Eli Lilly, and Pfizer.
The aim of the tool is to provide a quick approximation of the carbon impacts of pharmaceutical tablets in blister packs. This information can be used in assisting internal evaluations, assessing the carbon hot spots for individual products and screening product portfolios to prioritise more detailed footprinting studies and carbon reduction initiatives. In addition, it can be used to engage stakeholders in broader discussions around the carbon footprint impacts of products. The tool is specific to the UK pharmaceutical market.
You will need to acknowledge that you have read the terms and conditions before you can download the tool.